comparemela.com

பாலொ பைம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A Dangerous Divide: The Growing Debate over the Suspension of Vaccine Patents

DER SPIEGEL Suche öffnen A Dangerous Divide The Growing Debate over the Suspension of Vaccine Patents The U.S. no longer want to enforce patent protection for COVID-19 vaccines, but critics argue that this will do little to improve the lack of access in the developing world. Some are calling for much more ambitious solutions. Link kopieren During the more than three decades Brazilian Senator Paulo Paim has been a member of parliament, he has always been a voice for people who look up at the world from below. Paim has introduced laws aimed at establishing a minimum wage and at ensuring equality for Black people and the disabled. I am 71 years old, he says. I have fought so many battles. But none of them have been as important as this one.

Brazil Senate votes to suspend patent protection on COVID-19

By Ricardo Brito BRASILIA, April 29 (Reuters) - Brazil s Senate on Thursday approved a bill to suspend patent protection for COVID-19 vaccines, tests and medications during the pandemic, sending the proposal to the lower house of Congress for consideration and possible amendments. It remains unclear if lower house lawmakers will pass the bill, with implications for pharmaceutical firms such as AstraZeneca and China s Sinovac Biotech, which have arranged local production of their COVID-19 vaccines. U.S. firm Pfizer also made its first delivery of coronavirus vaccines to Brazil on Thursday evening. The government of President Jair Bolsonaro has publicly opposed proposals to suspend patent protections, arguing that such a move could endanger talks with vaccine producers.

UPDATE 2-Brazil Senate votes to suspend patent protection on COVID-19 vaccines

UPDATE 2-Brazil Senate votes to suspend patent protection on COVID-19 vaccines Reuters 4 hrs ago By Ricardo Brito BRASILIA, April 29 (Reuters) - Brazil s Senate on Thursday approved a bill to suspend patent protection for COVID-19 vaccines, tests and medications during the pandemic, sending the proposal to the lower house of Congress for consideration and possible amendments. It remains unclear if lower house lawmakers will pass the bill, with implications for pharmaceutical firms such as AstraZeneca and China s Sinovac Biotech, which have arranged local production of their COVID-19 vaccines. U.S. firm Pfizer also made its first delivery of coronavirus vaccines to Brazil on Thursday evening.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.